IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v5y2014i1d10.1038_ncomms5347.html
   My bibliography  Save this article

Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked

Author

Listed:
  • Malin K. Sandberg

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Huda Al-Doujaily

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Bernadette Sharps

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Michael Wiggins De Oliveira

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Christian Schmidt

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Angela Richard-Londt

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Sarah Lyall

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Jacqueline M. Linehan

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Sebastian Brandner

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Jonathan D. F. Wadsworth

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • Anthony R. Clarke

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

  • John Collinge

    (UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK)

Abstract

Prions are lethal infectious agents thought to consist of multi-chain forms (PrPSc) of misfolded cellular prion protein (PrPC). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrPC expression level, and a plateau (phase 2), which continues until clinical onset with duration inversely proportional to PrPC expression level. We hypothesized that neurotoxicity relates to distinct neurotoxic species produced following a pathway switch when prion levels saturate. Here we show a linear increase of proteinase K-sensitive PrP isoforms distinct from classical PrPSc at a rate proportional to PrPC concentration, commencing at the phase transition and rising until clinical onset. The unaltered level of total PrP during phase 1, when prion infectivity increases a million-fold, indicates that prions comprise a small minority of total PrP. This is consistent with PrPC concentration not being rate limiting to exponential prion propagation and neurotoxicity relating to critical concentrations of alternate PrP isoforms whose production is PrPC concentration dependent.

Suggested Citation

  • Malin K. Sandberg & Huda Al-Doujaily & Bernadette Sharps & Michael Wiggins De Oliveira & Christian Schmidt & Angela Richard-Londt & Sarah Lyall & Jacqueline M. Linehan & Sebastian Brandner & Jonathan , 2014. "Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked," Nature Communications, Nature, vol. 5(1), pages 1-7, September.
  • Handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5347
    DOI: 10.1038/ncomms5347
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms5347
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms5347?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5347. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.